Scorpion Therapeutics: Funding, Investors & Team (Sep 2026)
Scorpion Therapeutics was founded to expand the reach of precision medicine to more people with cancer. The company is integrating cutting-edge technologies across target discovery, medicinal chemistry, and translational medicine to deliver Precision Oncology 2.0, a pipeline of targeted small-molecule drugs that overcome the limitations of existing treatments. Scorpion’s experienced leadership team is executing a fit-to-purpose model to efficiently unlock the next generation of precision oncology. For more information, visit scorpiontx.com.
Scorpion Therapeutics has raised $312M across 2 funding rounds on record, the most recent a Series C of $150M announced in Jul 2024.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Scorpion Therapeutics Company Profile and Key Stats
Latest funding round on record: Jul 2024.
Scorpion Therapeutics Funding Rounds
Scorpion Therapeutics raised $162M in a Series B announced in Jan 2021.
3.5 years later, a Series C of $150M was announced in Jul 2024.
Scorpion Therapeutics Founders and Leadership Team
Contact details for the Scorpion Therapeutics team: 1 of 2 have an email address on file.
Start 14-day free trial →Scorpion Therapeutics Funding Compared to Other Biotechnology Startups
Scorpion Therapeutics' latest round of $150M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Scorpion Therapeutics in Biotechnology and Boston
Companies Similar to Scorpion Therapeutics
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Scorpion Therapeutics Funding FAQs
What does Scorpion Therapeutics do?
Scorpion Therapeutics was founded to expand the reach of precision medicine to more people with cancer. The company is integrating cutting-edge technologies across target discovery, medicinal chemistry, and translational medicine to deliver Precision Oncology 2.0, a pipeline of targeted small-molecule drugs that overcome the limitations of existing treatments. Scorpion’s experienced leadership team is executing a fit-to-purpose model to efficiently unlock the next generation of precision oncology. For more information, visit scorpiontx.com.
How much funding has Scorpion Therapeutics raised?
Scorpion Therapeutics has raised $312M across 2 rounds on record. The most recent is a Series C of $150M announced in Jul 2024.
When did Scorpion Therapeutics last raise funding?
Scorpion Therapeutics' most recent funding round on record is a Series C of $150M, announced in Jul 2024.
Who founded Scorpion Therapeutics?
FundedIQ lists Axel Hoos (Founder) at Scorpion Therapeutics.
Who is the CEO of Scorpion Therapeutics?
Gary Glick is listed as CEO at Scorpion Therapeutics.
Where is Scorpion Therapeutics headquartered?
Scorpion Therapeutics is based in Boston, Massachusetts, United States.
How many employees does Scorpion Therapeutics have?
Scorpion Therapeutics is in the 101-250 employee band.
How does Scorpion Therapeutics' funding compare to other Biotechnology startups?
Scorpion Therapeutics' latest round of $150M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's Scorpion Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Scorpion Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.